Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 2CENTRIENT PHARMACEUTICALS SPAIN S.A.
02 1ACS Dobfar S.p.A
03 2Aurobindo Pharma Limited
01 2Cefalexin Monohydrate
02 2Cephalexin
03 1Cephalexin Monohydrate
01 2India
02 1Italy
03 2Netherlands
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
NDC Package Code : 61303-007
Start Marketing Date : 2009-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
NDC Package Code : 61303-808
Start Marketing Date : 2007-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52946-0906
Start Marketing Date : 2009-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-230
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-338
Start Marketing Date : 2024-01-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
55
PharmaCompass offers a list of Cephalexin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cephalexin manufacturer or Cephalexin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cephalexin manufacturer or Cephalexin supplier.
PharmaCompass also assists you with knowing the Cephalexin API Price utilized in the formulation of products. Cephalexin API Price is not always fixed or binding as the Cephalexin Price is obtained through a variety of data sources. The Cephalexin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L-Keflex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Keflex, including repackagers and relabelers. The FDA regulates L-Keflex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Keflex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Keflex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Keflex supplier is an individual or a company that provides L-Keflex active pharmaceutical ingredient (API) or L-Keflex finished formulations upon request. The L-Keflex suppliers may include L-Keflex API manufacturers, exporters, distributors and traders.
click here to find a list of L-Keflex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L-Keflex as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L-Keflex API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L-Keflex as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L-Keflex and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L-Keflex NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L-Keflex suppliers with NDC on PharmaCompass.
We have 3 companies offering L-Keflex
Get in contact with the supplier of your choice:
